v3.20.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenue $ 3,958 $ 1,122 $ 59,505
Operating expenses      
Research and development (including losses accrued on firm purchase commitments of $0, $5,000 and $0) (91,568) (97,501) (98,269)
General and administrative (45,795) (43,391) (43,601)
Total operating expenses (137,363) (140,892) (141,870)
Operating loss (133,405) (139,770) (82,365)
Interest income 2,313 2,772 2,849
Other income (expense), net 1,162 75 (15,501)
Loss before income taxes (129,930) (136,923) (95,017)
Income taxes (162) (242) (497)
Net loss attributable to ordinary shareholders $ (130,092) $ (137,165) $ (95,514)
Net loss per ordinary share - Basic and diluted      
Basic and diluted (in dollars per share) $ (0.15) $ (0.22) $ (0.16)
Weighted average shares outstanding:      
Basic and diluted (in shares) 854,783,763 629,805,218 584,338,942
Development revenue      
Revenue $ 3,958 $ 1,122 $ 20,391
License revenue      
Revenue     $ 39,114

Source